Role of P-Glycoprotein in Distribution of Nelfinavir across the Blood-Mammary Tissue Barrier and Blood-Brain Barrier
- 1 April 2005
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 49 (4) , 1626-8
Abstract
As a first approach in understanding the possible efficacy and toxicity of human immunodeficiency virus protease inhibitors during breast feeding, the milk-to-plasma ratio of nelfinavir was determined in lactating rats. The milk-to-plasma ratio of nelfinavir was determined to be 0.56 ± 0.10 (means ± standard deviations). Western blotting indicated that P-glycoprotein is expressed in rat mammary and brain tissue; however, the multidrug-resistant modulator GF120918 showed a significant effect only at the blood-brain barrier and not at the mammary-epithelial tissue barrier.Keywords
This publication has 11 references indexed in Scilit:
- Breast-Feeding and HIV-1 Transmission in Resource-Limited SettingsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2002
- Effects of a P-Glycoprotein Inhibitor on Brain and Plasma Concentrations of Anti-Human Immunodeficiency Virus Drugs Administered in Combination in RatsDrug Metabolism and Disposition, 2002
- Transporter Gene Expression in Lactating and Nonlactating Human Mammary Epithelial Cells Using Real-Time Reverse Transcription-Polymerase Chain ReactionThe Journal of Pharmacology and Experimental Therapeutics, 2002
- Pharmacological Inhibition of P-glycoprotein Transport Enhances the Distribution of HIV-1 Protease Inhibitors into Brain and TestesDrug Metabolism and Disposition, 2000
- Human Immunodeficiency Virus Protease InhibitorsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1999
- Safety, Pharmacokinetics, and Antiretroviral Activity of the Potent, Specific Human Immunodeficiency Virus Protease Inhibitor Nelfinavir: Results of a Phase I/II Trial and Extended Follow‐up in Patients Infected with Human Immunodeficiency VirusThe Journal of Clinical Pharmacology, 1998
- HIV-Protease InhibitorsNew England Journal of Medicine, 1998
- Preformulation Studies of a Novel HIV Protease Inhibitor, AG1343Journal of Pharmaceutical Sciences, 1995
- Central nervous system targeting of 2',3'-dideoxyinosine via adenosine deaminase-activated 6-halo-dideoxypurine prodrugsAntimicrobial Agents and Chemotherapy, 1992
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTJournal of Biological Chemistry, 1951